Abortions (Spontaneous and Elective) and Related Complications — Clinical Documentation Guide (2026)

🔍 Definition

An abortion, in obstetric and medical coding contexts, refers to the termination of a pregnancy before the fetus reaches viability — generally defined as fewer than 20 completed weeks of gestation or a fetal weight under 500 grams (CDC NCHS, Definitions of Vital Statistics). Abortions are broadly classified by etiology (spontaneous vs. induced/elective), completeness (complete vs. incomplete), and the presence or absence of complications. Under FY2026 ICD-10-CM Official Coding Guidelines (Section I.C.15), all obstetric conditions are presumed related to the pregnancy unless the physician documents otherwise.

• Spontaneous abortion (miscarriage): Unintentional, non-induced loss of a pregnancy, classified under category O03. May be complete (all products of conception expelled) or incomplete (partial retention of products of conception).
• Elective/induced termination: Intentional termination of pregnancy by medical or surgical means. Z33.2 is assigned for an encounter for elective termination of pregnancy without complications; O04 is used when complications arise following induced termination.
• Failed attempted termination (O07): Attempted termination that did not result in expulsion, with or without complications.
• Missed abortion (O02.1): Fetal demise without expulsion of products of conception; no cramping or bleeding has occurred.
• Threatened abortion (O20.0): Hemorrhage in early pregnancy with a closed cervical os and a viable intrauterine pregnancy still present.
• Habitual aborter / Recurrent pregnancy loss (N96): Three or more consecutive spontaneous abortions; coded N96 when not currently pregnant.

🗂️ Alternative Terminology

The following terms appear in medical records, operative reports, and physician notes and map to specific ICD-10-CM categories:

🩺 Signs & Symptoms

Clinical presentation varies significantly depending on the type of abortion and presence of complications. Key signs and symptoms that drive code selection include (ACOG Practice Bulletin No. 200 — Early Pregnancy Loss):

• Vaginal bleeding: Ranges from spotting (threatened abortion) to heavy hemorrhage (incomplete/complete); hemorrhage is a key complication flag for O03.1, O03.6
• Pelvic/lower abdominal cramping or pain: Uterine contractions expelling products of conception
• Passage of tissue: Products of conception, gestational sac, or placental tissue — indicates expulsion
• Closed cervical os with bleeding: Hallmark of threatened abortion (O20.0)
• Open/dilated cervical os: Indicative of inevitable or incomplete abortion
• Fever, chills, uterine tenderness: Signs of septic abortion (O03.0, O03.5) — requires urgent intervention
• Hypotension, tachycardia: May indicate septic shock (O03.0, O03.5) or hemorrhagic shock
• Absent fetal cardiac activity on ultrasound with no bleeding: Classic presentation of missed abortion (O02.1)
• Nausea, vomiting: Non-specific; relevant when persistent post-procedure
• Urinary symptoms, oliguria: Suggests renal complications (O03.32, O03.82)

🧭 Differential Diagnosis

Early pregnancy loss and abortion-related presentations may share symptoms with other conditions. The following differential diagnoses are relevant for coders and CDI specialists when documentation is incomplete (American Family Physician — Evaluation and Management of First-Trimester Bleeding):

📋 Clinical Indicators for Coders/CDI

The following clinical indicators determine code assignment specificity and drive CDI queries. Per FY2026 ICD-10-CM Guidelines Section I.C.15.q, abortions require documentation of completeness, trimester (when applicable), and complications to reach maximum specificity.

🦴 Anatomy & Pathophysiology

Understanding the underlying mechanism informs both clinical management and coding specificity.

Normal Early Pregnancy Architecture

At the time of implantation (approximately 6–10 days post-fertilization), the blastocyst embeds in the decidualized endometrium. The trophoblast differentiates into the syncytiotrophoblast and cytotrophoblast, forming the placenta and chorion. The yolk sac and embryo develop within the gestational sac (ACOG Practice Bulletin 200). Human chorionic gonadotropin (hCG) maintains the corpus luteum until the placenta assumes progesterone production.

Pathophysiology of Spontaneous Abortion

Approximately 50–60% of first-trimester spontaneous abortions are caused by chromosomal abnormalities in the embryo (ACOG Practice Bulletin 200). Other etiologies include:

• Chromosomal/genetic factors: Aneuploidy (trisomy 16 most common); accounts for the majority of first-trimester losses
• Uterine anatomic abnormalities: Septate uterus, fibroids, Müllerian anomalies — associated with recurrent pregnancy loss (N96)
• Antiphospholipid antibody syndrome (APS): Leading treatable cause of recurrent loss; hypercoagulable placental environment
• Endocrine disorders: Uncontrolled diabetes, thyroid dysfunction, luteal phase deficiency
• Uterine/cervical incompetence: Painless second-trimester losses; associated with habitual aborter pattern
• Infections: Listeria, Toxoplasma, CMV, group B streptococcus — can precipitate septic abortion

Mechanism of Septic Abortion

Septic abortion occurs when retained products of conception become infected, allowing ascending bacterial contamination (typically polymicrobial — Escherichia coli, Bacteroides, Streptococcus) to progress to endometritis, parametritis, or systemic bacteremia/sepsis. Left untreated, septic shock (O03.0, O03.5) carries significant maternal morbidity and mortality.

Mechanism of Failed Medical Abortion

Medical abortion typically uses mifepristone (progesterone receptor antagonist) followed by misoprostol (prostaglandin E1 analogue). Failure occurs when the embryo is not expelled, the gestational sac remains intact, or incomplete expulsion occurs (O07.x). Failure rates range from 2–5% at recommended gestational ages (FDA-approved labeling for Mifeprex (mifepristone)).

💊 Medication Impact / Treatment

Pharmacologic management is central to both medical abortion and treatment of complications. The following medications directly affect code selection and CDI documentation:

Medical Abortion Regimen

• Mifepristone (Mifeprex): 200 mg oral; antiprogesterone; used in combination with misoprostol for medical abortion up to 70 days gestation. HCPCS S0190 (mifepristone 200 mg). Approved under FDA REMS program (FDA Mifeprex Labeling 2023).
• Misoprostol (Cytotec): 800 mcg buccal/vaginal; prostaglandin E1 analogue; used alone or with mifepristone. No specific HCPCS J-code; billed as unclassified or under NDC-level billing in some states. HCPCS S0191 refers to misoprostol 200 mcg.

Treatment of Incomplete/Septic Abortion

• Oxytocin (Pitocin): Uterotonic to assist expulsion of retained products; reduces hemorrhage
• Methylergonovine (Methergine): Uterotonic; used post-procedure to prevent hemorrhage
• Broad-spectrum antibiotics: Mandatory for septic abortion; typically IV doxycycline + cefoxitin, or metronidazole-based regimens per CDC STI Treatment Guidelines 2021. Document organism, antibiotic use, and response for CDI purposes.
• IV fluid resuscitation / vasopressors: Required in septic shock — document as complication of abortion (O03.0 / O03.5) and code sepsis separately per guidelines
• Rho(D) immune globulin (RhoGAM): Administered to Rh-negative patients following spontaneous or induced abortion to prevent isoimmunization. Not a complication code; add Z29.11 (encounter for prophylactic RhoGAM) if applicable.

Preview ends here. The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO Members.

← Back to All Clinical Documentation Guides